BioInvent International
Bioinvent: Interview with CEO Martin Welschof (video) (Redeye)
2021-10-15 09:00
Redeye talked to Martin Welschof, CEO of BioInvent, about the company's clinically most advanced asset (BI-1206) and its other programs. We also discussed its "war chest" and the uniqueness of its research.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se